


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.82%
-2.92%
+2.65%
-1.90%
ERAS
Erasca
$9.90

Login to see Erasca (ERAS) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Upgraded on attractively valued
Technical Indicators

Oversold
ERAS Price Performance
$16.18 (-38.81%)
$10.61 (-6.69%)
$3.29 (+200.91%)
$1.33 (+644.36%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ERAS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ERAS Street Sentiment is bullish and have positive views on the near-term outlook
ERAS has Extreme risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Apr 13, 2026
Reiterate
Buy
Jefferies
What is ERAS current stock price?
What are ERAS stock strengths?
What is ERAS Risk Level?
What is ERAS market cap and volume?
What is ERAS current Stock IQ?
Should I buy ERAS stock right now?
Is ERAS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ERAS?
What does a 'Strong Sell' rating mean for ERAS?
What factors influence ERAS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ERAS
Erasca
Current Price
$9.90

ERAS Price Performance
$16.18 (-38.81%)
$10.61 (-6.69%)
$3.29 (+200.91%)
$1.33 (+644.36%)
ERAS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ERAS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ERAS Street Sentiment is bullish and have positive views on the near-term outlook
ERAS has Extreme risk level
Average key support and resistance price levels
Overall Wall Street Rating
ERAS Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued
Technical Indicators

Oversold
ERAS Trading Signals
ERAS is now at $9.90, down -48.30% from $19.15. This rapid movement warrants attention.
ERAS is experiencing a volume spike with 51.02M shares traded, 8.55x its average volume of 5.97M. This indicates strong selling pressure.
ERAS is showing high volatility with an intraday swing of 21.84% (High: $10.60, Low: $8.70). This signals potential risk.
ERAS is showing oversold conditions with RSI at 29.98 (below 30). This may signal a potential upward reversal or buying opportunity.
ERAS has a bearish MACD crossover with MACD (0.73) crossing below Signal (1.31). This signals negative momentum shift.
ERAS has negative earnings news: Missed Estimate. Rambus Posts Downbeat Q1 Earnings Joins Erasca Spotify Amkor Technology And Other Big Stocks Moving Lower In Tuesdays Pre-Market Session. United Stat...
ERAS missed earnings expectations. Rambus Posts Downbeat Q1 Earnings Joins Erasca Spotify Amkor Technology And Other Big Stocks Moving Lower In Tuesdays Pre-Market Session. United Stat...
ERAS received an analyst price target change. BofA raises Erasca stock price target to $9 on trial data....
ERAS Stock IQ dropped from 4.88 to 2.80, reflecting a weakened outlook.
ERAS Stock IQ sentiment changed from Strong Bullish to Neutral, reflecting a changed outlook.
ERAS opened with a gap down of 45.12% (prev close $19.15, open $10.51)
ERAS has closed down for 3 consecutive days
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ERAS Stock trends
ERAS Stock performance
ERAS Stock analysis
ERAS investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
The market is trading earnings dispersion, with margin pressure and forward guidance driving sharp repricing rather than broad index direction.
Read More →Erasca collapsed sharply after a clinical setback, with shares down -...